INSR and Hyperglycemia: The same group of investigators also reported that daily taVNS applications for 34 consecutive days prevented development of hyperglycemia in Zucker diabetic fatty rats and increased insulin receptor expression in various tissues, including liver and skeletal muscle (Li et al., 2014).